IRIS
MAIDA, Ivana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.186
EU - Europa 4.791
AS - Asia 4.518
SA - Sud America 2.838
AF - Africa 178
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 13
Totale 19.540
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.030
BR - Brasile 2.530
SG - Singapore 1.909
IT - Italia 1.874
CN - Cina 1.388
UA - Ucraina 940
HK - Hong Kong 469
DE - Germania 449
FR - Francia 438
SE - Svezia 268
FI - Finlandia 194
VN - Vietnam 178
GB - Regno Unito 118
AR - Argentina 113
IE - Irlanda 97
NL - Olanda 77
RU - Federazione Russa 77
TR - Turchia 73
BD - Bangladesh 60
MX - Messico 58
CA - Canada 55
IQ - Iraq 53
EC - Ecuador 52
ZA - Sudafrica 52
IN - India 49
PL - Polonia 42
CZ - Repubblica Ceca 41
PK - Pakistan 40
MA - Marocco 35
ES - Italia 34
KR - Corea 34
UZ - Uzbekistan 31
CO - Colombia 30
JP - Giappone 29
BE - Belgio 27
VE - Venezuela 26
AT - Austria 24
AZ - Azerbaigian 23
ID - Indonesia 23
PY - Paraguay 23
UY - Uruguay 20
AE - Emirati Arabi Uniti 19
IR - Iran 19
KE - Kenya 19
PE - Perù 18
TN - Tunisia 17
AU - Australia 16
CL - Cile 16
DZ - Algeria 15
KZ - Kazakistan 15
EG - Egitto 14
JO - Giordania 12
EU - Europa 11
CH - Svizzera 10
IL - Israele 10
NP - Nepal 10
PA - Panama 10
LB - Libano 9
LT - Lituania 9
RS - Serbia 9
BO - Bolivia 8
HU - Ungheria 8
AL - Albania 7
DO - Repubblica Dominicana 7
PS - Palestinian Territory 7
SA - Arabia Saudita 7
SN - Senegal 7
BG - Bulgaria 6
BH - Bahrain 6
CR - Costa Rica 6
GE - Georgia 6
JM - Giamaica 6
OM - Oman 6
QA - Qatar 6
BY - Bielorussia 5
GA - Gabon 5
KG - Kirghizistan 5
KW - Kuwait 5
BA - Bosnia-Erzegovina 4
HN - Honduras 4
MD - Moldavia 4
MK - Macedonia 4
NG - Nigeria 4
NI - Nicaragua 4
PH - Filippine 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
GR - Grecia 3
SI - Slovenia 3
AM - Armenia 2
BN - Brunei Darussalam 2
CY - Cipro 2
GT - Guatemala 2
HR - Croazia 2
ML - Mali 2
NO - Norvegia 2
TL - Timor Orientale 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 19.518
Salva come PNG Salva come JPEG
Città #
Dallas 2.601
Singapore 1.043
Chandler 913
Jacksonville 557
Hong Kong 464
Princeton 332
Beijing 300
Nanjing 254
Ashburn 187
Dearborn 187
São Paulo 175
Rome 160
New York 143
Milan 132
Wilmington 124
Shanghai 109
Boardman 108
Nanchang 103
Sassari 101
Ann Arbor 97
Dublin 96
Los Angeles 93
Rio de Janeiro 87
Ho Chi Minh City 78
Shenyang 75
Belo Horizonte 66
Naples 63
Tianjin 62
Munich 59
Santa Clara 58
Woodbridge 50
Hebei 48
Changsha 46
Florence 46
Helsinki 44
Brasília 43
Hanoi 41
Porto Alegre 41
Andover 37
Brno 37
Jiaxing 37
Campinas 35
Jinan 34
Seoul 32
Nuremberg 31
Hangzhou 30
Tashkent 30
Buffalo 29
Curitiba 29
Guarulhos 29
San Francisco 29
Goiânia 28
Ningbo 28
Palermo 28
Brussels 27
Tokyo 27
Toronto 27
Warsaw 27
Bari 26
Ribeirão Preto 25
Turin 25
Zhengzhou 25
Norwalk 24
Bologna 22
Kunming 22
Baku 21
Johannesburg 21
Salvador 21
Sorocaba 21
Baghdad 20
Fortaleza 20
Montevideo 20
Turku 20
Dhaka 19
Montreal 18
Brooklyn 17
Buenos Aires 17
Campo Grande 17
Chicago 17
Juiz de Fora 17
London 17
Nairobi 17
São José dos Campos 17
Verona 17
Betim 16
Caxias do Sul 16
Columbus 16
Recife 16
Santo André 16
São Bernardo do Campo 16
Ardabil 15
Atlanta 15
Guangzhou 15
Joinville 15
San Mateo 15
Denver 14
Frankfurt am Main 14
Leawood 14
Lima 14
Nova Iguaçu 14
Totale 10.561
Salva come PNG Salva come JPEG
Nome #
CASE REPORT: MIOCARDITE ACUTA DA CITOMEGALOVIRUS IN GIOVANE PAZIENTE IMMUNOCOMPETENTE 1.772
Accertamento diagnostico di meningoencefalite da Listeria monocytogenes mediante PCR in soggetti immunocompetenti 269
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 259
Analisi dell'attività dei C.I.O. in ambito regionale e proposta di un modello organizzativo - funzionale 213
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 202
Analisi del case-mix ospedaliero. Il controllo dei ricoveri outlier 201
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 186
Strategie di sorveglianza attiva e networking per il controllo delle infezioni da L. monocytogenes 177
Andamento della parotite epidemica nell’Azienda USL n.1 di Sassari e considerazioni sulle strategie vaccinali 168
Aspetti epidemiologici di infezioni gastroenteriche in paesi in via di sviluppo 168
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 167
Aspetti epidemiologici sulla colonizzazione da Streptococcus agalactiae nelle donne in gravidanza. 165
alpha-and gamma-tocophetol modulate the apoptotic signaling induced by oxidized low-density lipoprotein in human coronaric smooth muscle cells 165
Approccio molecolare nello studio di un episodio infettivo ospedaliero da Pseudomonas aeruginosa 160
Approccio molecolare nella diagnosi della tubercolosi umana 155
Antibiotic resistant H-pylori are extremely common in Sardinia. 155
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 154
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 154
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 153
Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C 148
Associazione sierologia tra HIV e Trichomonas vaginalis nella popolazione femminile del Nord-Sardegna. 146
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 145
Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. 143
Genotypic characterization of clarithromycin-resistant Helicobacter pylori strains 129
Andamento delle infezioni nosocomiali nel complesso chirurgico Università- Azienda USL n. 1- Sassari. 129
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 127
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 127
PREVENTION OF TRAVEL ASSOCIATED INFECTION DUE TO LEGIONELLA: MICROBIOLOGIC ANALYSIS IN LINERS AND CRUISE SHIPS 126
Clonal relationships among Salmonella enteritidis phage type 3 outbreak isolates traced by DNA fingerprinting 126
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 125
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 123
Utilizzo della metodologia bayesiana per lo studio della variazione geografica del rischio in epidemiologia. 122
Valutazione della qualità delle schede di dimissione ospedaliera 122
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 119
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution 118
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 117
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 114
Occurrence of infections during combination treatment with interferons and ribavirin for chronic hepatitis C: Role of neutropenia and of interferon pegylation 114
Listeria monocytogenes meningoencephalitis: molecular methods for diagnosis and for monitoring the response to chemotherapy 113
Comparison of 2D Shear Wave Elastography and Transient Elastography in Non-Invasive Evaluation of Liver Fibrosis in Hepatitis C Virus-Related Chronic Liver Disease 112
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcome 112
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 110
Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes 110
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 109
Neurocognitive performance and cardiovascular risk in a cohort of HIV-infected patients 109
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 109
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 108
QuantiFERON TB Gold: a new method for latent tuberculosis infection 108
Epidemiology of Salmonellosis in Sardinia, Italy: 1995-2001 107
HIV related aneurisms 107
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 106
Characterization of resistance profiles in HCV 2-3-4 DAA-naive and DAA-experienced infected patients in Italy 106
Inquinamento ambientale nelle sale operatorie. Nota II: condizioni microclimatiche e microbiologiche 106
Rapid detection and identification of Mycobacterium tuberculosis by Real Time PCR and Bactec 960 MIGT 105
OPERA: use of pegylated interferon plus ribavirin for treating hepatitis C/HIV co-infection in interferon-naive patients. 105
Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus 105
Joint replacement for avascular necrosis in people living with HIV 105
Pulmonary Involvement in Recurrent Respiratory Papillomatosis: A Systematic Review 103
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 103
Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience 103
Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients 102
Genetic determinants in critical domains of NS5A are associated with genotype 1b HCV-induced hepatocellular carcinoma 102
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir. 102
Hepatitis C virus-RNAclearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin 101
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 100
Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study. 100
Monitoraggio di metalli pesanti nelle acque costiere della Sardegna settentrionale mediante utilizzo di indicatori biologici 100
Epidemiologia e prevenzione delle infezioni da Micobatteri su base molecolare 100
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 100
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 100
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 100
Predictors of Virological Response to Atazanavir in Protease Inhibitor-Experienced Patients 99
Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir 98
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 98
Serum homocysteine levels are increased in women with gestational diabetes mellitus 96
Modulation by α- and γ-tochopherol and oxidized low density lipoprotein in human coronaric smooth muscle cells 96
Database per il monitoraggio del rischio professionale negli operatori sanitari 95
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes 95
Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies 94
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection. 94
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 93
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies 93
Characteristics and Prospects for Hepatitis C Therapy of an HIV-HCV Coinfected Population Followed at a Reference HIV Center 93
Failure of Hepatitis C Therapy in HIV-Coinfected Drug Users Is Not Due to a Shift in Hepatitis C Virus Genotype 93
Specific Genetic Determinants in NS5A and Core Regions Correlate with Genotype 1b HCV-Induced Hepatocellular Carcinoma: Implications for Viral Markers of Disease Progression 93
Surveillance of Poliomyelitis in Italy: immunity status of population against polio and environmental circulation of Poliovirus. General illustration of the results 93
Evalutaion and comparison of molecular techniques for epidemiological typing of M. tuberculosis 92
Upper Gastrointestinal Bleeding May Unmask Didanosine-Associated Portal Hepatopathy in HIV/HCV Co-infected Patients 91
Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation 91
Simplification From Protease Inhibitors to Once- or Twice-Daily Raltegravir: The ODIS Trial 91
Database per il monitoraggio del rischio professionale negli operatori sanitari 91
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 90
Severe portal hypertension in HIV patients with no primary liver disease: prevalence, histology and potential etiology 90
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir 89
Liver Fibrosis Stage and HCV Genotype Distribution in HIV-HCV Coinfected Patients with Persistently Normal Transaminases 88
Triple-nucleoside regimens versus efavirenz 88
Rate of Virologic Failure and Selection of Drug Resistance Mutations Using Different Triple Nucleos(t)ide Analogue Combinations in HIV-Infected Patients 88
New paradigms in the management of HIV and hepatitis C virus coinfection 88
Very late HCV relapse following triple therapy for hepatitis C. 87
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome 87
Totale 13.605
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.273
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.273
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021929 0 0 0 0 0 82 164 16 244 230 138 55
2021/2022965 152 27 24 46 18 19 45 67 77 32 110 348
2022/20231.962 199 101 39 314 190 334 21 222 331 25 108 78
2023/2024930 105 62 32 41 193 96 27 52 16 57 97 152
2024/20255.792 113 161 376 136 197 193 360 1.074 1.964 763 314 141
2025/20265.633 345 1.982 1.231 1.222 735 118 0 0 0 0 0 0
Totale 19.869